Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity

被引：0
|
作者：
Diab, A. [1 ]
Abdel-Wahab, N. [2 ]
Johnson, D. H. [3 ]
Hailemichael, Y. [1 ]
Foo, W. C. [1 ]
Bentebibel, S-E. [1 ]
Lizee, G. A. [1 ]
Ekmekcioglu, S. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Melanoma Med Oncol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Gen Internal Med & Melanoma Med Oncol, Houston, TX 77030 USA
[3] Ochsner Clin Fdn, Ochsner Med Ctr, New Orleans, LA USA
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.10.090
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
72P
引用
收藏
页码：S1403 / S1403
页数：1
相关论文
共 50 条
  • [1] Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity
    Hailemichael, Yared
    Johnson, Daniel H.
    Abdel-Wahab, Noha
    Foo, Wai Chin
    Bentebibel, Salah-Eddine
    Daher, May
    Haymaker, Cara
    Wani, Khalida
    Saberian, Chantal
    Ogata, Dai
    Kim, Sang T.
    Nurieva, Roza
    Lazar, Alexander J.
    Abu-Sbeih, Hamzah
    Fa'ak, Faisal
    Mathew, Antony
    Wang, Yinghong
    Falohun, Adewunmi
    Van Trinh
    Zobniw, Chrystia
    Spillson, Christine
    Burks, Jared K.
    Awiwi, Muhammad
    Elsayes, Khaled
    Soto, Luisa Solis
    Melendez, Brenda D.
    Davies, Michael A.
    Wargo, Jennifer
    Curry, Jonathan
    Yee, Cassian
    Lizee, Gregory
    Singh, Shalini
    Sharma, Padmanee
    Allison, James P.
    Hwu, Patrick
    Ekmekcioglu, Suhendan
    Diab, Adi
    CANCER CELL, 2022, 40 (05) : 509 - +
  • [2] INTRACELLULAR RETENTION OF INTERLEUKIN-6 ABROGATES SIGNALING
    ROSEJOHN, S
    SCHOOLTINK, H
    SCHMITZVANDELEUR, H
    MULLBERG, J
    HEINRICH, PC
    GRAEVE, L
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1993, 268 (29) : 22084 - 22091
  • [3] Lack of interleukin-6 in the tumor microenvironment augments type-1 immunity and increases the efficacy of cancer immunotherapy
    Ohno, Yosuke
    Toyoshima, Yujiro
    Yurino, Hideaki
    Monma, Norikazu
    Xiang, Huihui
    Sumida, Kentaro
    Kaneumi, Shun
    Terada, Satoshi
    Hashimoto, Shinichi
    Ikeo, Kazuho
    Homma, Shigenori
    Kawamura, Hideki
    Takahashi, Norihiko
    Taketomi, Akinobu
    Kitamura, Hidemitsu
    CANCER SCIENCE, 2017, 108 (10): : 1959 - 1966
  • [4] Transgenic blockade of interleukin 6 transsignaling abrogates inflammation
    Rabe, Bjorn
    Chalaris, Athena
    May, Ulrike
    Waetzig, Georg H.
    Seegert, Dirk
    Williams, Anwen S.
    Jones, Simon A.
    Rose-John, Stefan
    Scheller, Jurgen
    BLOOD, 2008, 111 (03) : 1021 - 1028
  • [5] Immunotherapeutic Interleukin-6 or Interleukin-6 Receptor Blockade in Cancer: Challenges and Opportunities
    Kampan, Nirmala Chandralega
    Xiang, Sue D.
    McNally, Orla M.
    Stephens, Andrew N.
    Quinn, Michael A.
    Plebanski, Magdalena
    CURRENT MEDICINAL CHEMISTRY, 2018, 25 (36) : 4785 - 4806
  • [6] INTERLEUKIN-1, INTERLEUKIN-6 AND TUMOR NECROSIS FACTOR IN INFECTION, INFLAMMATION AND IMMUNITY
    BENDTZEN, K
    IMMUNOLOGY LETTERS, 1988, 19 (03) : 183 - 192
  • [7] The biology of Interleukin-6 and strategies of blockade
    Rose-John, Stefan
    CYTOKINE, 2015, 76 (01) : 59 - 59
  • [8] Faecalibacterium prausnitzii Abrogates Intestinal Toxicity and Promotes Tumor Immunity to Increase the Efficacy of Dual CTLA4 and PD-1 Checkpoint Blockade
    Gao, Yaqi
    Xu, Pingping
    Sun, Danfeng
    Jiang, Yi
    Lin, Xiao-Lin
    Han, Ting
    Yu, Jun
    Sheng, Chunquan
    Chen, Haoyan
    Hong, Jie
    Chen, Yingxuan
    Xiao, Xiu-Ying
    Fang, Jing-Yuan
    CANCER RESEARCH, 2023, 83 (22) : 3710 - 3725
  • [9] Harnessing GVHD by interleukin-6 receptor blockade
    Finke, Juergen
    Zeiser, Robert
    LANCET ONCOLOGY, 2014, 15 (13): : 1411 - 1412
  • [10] Interleukin-6: Biology, signaling and strategies of blockade
    Schaper, Fred
    Rose-John, Stefan
    CYTOKINE & GROWTH FACTOR REVIEWS, 2015, 26 (05) : 475 - 487
12345